Genomic Opportunities for Studying Sickle Cell Disease
Manchester Grand Hyatt, America's Cup Room A-B
San Diego, California
December 8-9, 2011
Over the course of the workshop, the group considered the following questions:
- Opportunity: What do we know now about sickle cell disease that points to the potential for genomic technologies to enhance our understanding of the disorder and to reduce the burden of the disease?
- Design: What strategies should be applied to utilize genomic technologies to meet these opportunities?
- Challenges: What are the greatest obstacles to the effective use of genomic technologies for these studies?
- Ethical, Legal and Social Implications (ELSI): What are the social and ethical issues that should be considered and addressed to advance the use of genomic technologies in the United States and globally?
The workshop was sponsored by the National Human Genome Research Institute (NHGRI), the National Heart, Lung, and Blood Institute (NHLBI), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Institute on Minority Health and Health Disparities (NIMHD), and the National Institute of Neurological Disorders and Stroke (NINDS).
Last Updated: June 11, 2012